Dr Peng Lee

Haematologist/Lymphomaniac/HSANZ President. Kiwi/South Australian. Introvert/INFJ and Wife/Default Parent. Tweets/Views are all my own.

[Dr Peng Lee @HuiPengLee1]

HSANZ is proud to announce the launch of the Australian National AML Clinical Guidelines available at the link below, endorsed by the Australian DHAC. Thank you to all the leads and contributors of this phenomenal milestone for Blood Cancer 🥰🩸👊
#HSANZ #healthleadership

[HSANZ @hsanz_org_au]

Australian National AML Clinical Guidelines now available! Expert-driven, evidence-based treatment recommendations from the Australian haematology community to support informed decisions & improve patient outcomes.
🔗 https://t.co/FGVjZnjuGt
#AML #Haematology #BloodCancer

[Dr Peng Lee @HuiPengLee1]

HSANZ is hiring!! Please click the link to apply for our principal administrative officer for the Haematology Society, currently located with Sydney CBD offices but nationwide applicants highly welcome. Come join our dynamic society! 🩸🤩

https://t.co/tKhlgILsGW

[Arina Martynchyk @MartynchykArina]

Everything’s possible with the best teacher and mentors @DrElizaHawkes, @NicoleWongDoo and great support of @ALLGtrials @hsanz_org_au. Thank you! Can’t wait to start!

[Dr Peng Lee @HuiPengLee1]

HSANZ Council thanks all delegates, sponsors and partner organisations who helped make #Blood2024 the scientific event of the year! See you next year in Perth 🤓🥰
@hsanz_org_au @ANZSBT @THANZBlood

[Dr Peng Lee @HuiPengLee1]

Sooo privileged and grateful to have been able to host such excellent expert speakers and guests! Safe travels to all #Blood2024

[Carlos Fernandez de Larrea @fdezdelarrea]

So thankful to the Hematology Society of Australia and New Zealand for the invitation to participate in their meeting in Brisbane, sharing our experience with ARI0002h #Blood2024 @hospitalclinic @idibaps @UniBarcelona @hsanz_org_au

[Katherine Creeper @KJClots]

So proud of @KatieLe81591036 for her HSANZ clinical fellowship award! @hsanz_org_au #Blood2024

[Erica Wood @erica_m_wood]

Congratulations @MMKingT! Fantastic to see your contributions recognised by @hsanz_org_au in this way!

[Gareth Gregory @DrGarethGregor1]

Two (2!) fantastic IIT abstracts in the HSANZ Presidential Symposium from @DrElizaHawkes (RaDD) and @AllisonBarra1 (WAMM) from their @ONJCRI group at #Blood2024 @WomenInLymphoma @ALLGtrials 👏 🩸

[Women in Lymphoma - [email protected] @WomenInLymphoma]

https://t.co/9wliiPcA6j
@hsanz_org_au @LeukaemiaAus #Scholarships #Awards #Fellowships #Grants

[HSANZ @hsanz_org_au]

🔬 Unlock your future in haematology! Applications open for Scholarships and Fellowships: https://t.co/5QN1Rbow3z
#HSANZ #Haematology #Research #Fellowships

[Dr Peng Lee @HuiPengLee1]

A privilege to be able to advocate for equitable access to CAR-T therapy for all patients in Parliament House, with a courageous number of patients, their families, astounding colleagues, and amazing advocacy group. Collaboration and cohesiveness is key. #HSANZ #lymphomaOz

[Gareth Gregory @DrGarethGregor1]

Amazing day to be at Parliament House in Canberra for a CART advocacy panel with some incredible patients, government, industry, @lymphomaOz , HSANZ President-Elect ⁦@HuiPengLee1⁩ (pictured) and @mike_dickinson1 🙏

[Dr Peng Lee @HuiPengLee1]

@thanosdimop Congratulations, such superb work by all, very grateful to have been part of this collaboration ☺️

[Thanos Dimopoulos @thanosdimop]

We are proud to have another publication in WM: "Zanubrutinib Versus
Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis
From the Randomized Phase III ASPEN Study," (Journal of Clinical Oncology,
21/7/2023)

https://t.co/WqEDyxV60m

[Australasian Leukaemia & Lymphoma Group (ALLG) @ALLGtrials]

Congratulations to Dr @emma_verner who presented ALLG trial NHL29 IRIC poster at this week’s International Conference on Malignant Lymphoma #17ICML. Dr Verner also presented @EHA_Hematology. For more on NHL29, see pp 72 of our latest Research Report https://t.co/CZaSacB7QK

[Australasian Leukaemia & Lymphoma Group (ALLG) @ALLGtrials]

Great group shot at #EHA2023! L-R: Mary Ann Anderson, Peng Lee, Emma Verner, Judith Trotman, Surrender Juneja, & our CEO Delaine Smith at NHL29 IRIC poster. You can learn more about this trial on page 72 of our latest Research Report https://t.co/CZaSacBFGi

[HSANZ @hsanz_org_au]

https://t.co/uL0GARFxih Abstracts close in two weeks on 31 May.
This is a unique opportunity to further your career and gain professional recognition, present your research and enhance the field of haematology in both Australia and New Zealand
#blood2023 #haematology

[Women in Lymphoma - [email protected] @WomenInLymphoma]

💜 @WomenInLymphoma Celebrating 800+ global members in 40+ countries 🌍 including 15% males ♂️ #heforshe + almost 3,000 Twitter followers! 🌎
#globaladvocacy #WomenInMedicine #webinars #mentoring #leadership

[Australasian Leukaemia & Lymphoma Group (ALLG) @ALLGtrials]

We congratulate ALLG Associate Registrar/Trainee members who are @hsanz_org_au award recipients for 2022! HSANZ Leukaemia Foundation PhD Scholarship: Sun Loo & Briony Shaw. HSANZ New Investigator Clinical Fellowship: Matthew Rees. HSANZ Snowdome mid-career award: Siok-Keen Tey.

[Graham Collins @graham74GC]

The end of W&W for low tumour burden, asymp FL?
- long term FU UK W&W study (12y)
- Med TTNT: 2.7y v 9.9y v NR (W&W / R inducn / RI+Mx)
- no effect time to 2nd Rx, high grade Tx, 2nd prim malig
- BUT on W&W arm, some never needed Rx
- What about in COVID era?
Great work. #ASH22

[Dr Peng Lee @HuiPengLee1]

Interestingly, negroni with “proper” ice look like lymphocytes swimming in blood 🩸😜. Pretty cool. #alwsysmyfavouritewhitecell